Henan Lingrui Pharmaceutical Co.,Ltd.’s Net Profit Rose 17.1% in First Half of 2023

Henan Lingrui Pharmaceutical Co.,Ltd. (河南羚锐制药股份有限公司) (600285.SH) reported a net profit of 317 million yuan in the first half of 2023, up 17.1% year-on-year.

Meanwhile, the company posted 1.7 billion yuan in revenue, up 13.2% year-on-year.

At the end of the reporting period, it had 4.3 billion yuan in total assets and 1.8 billion yuan in total liabilities, with a liability-to-asset ratio of 41.3%.